{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:42:05Z","timestamp":1753519325949,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-021-02303-1","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T09:03:01Z","timestamp":1637571781000},"page":"265-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Levamisole-induced\u00a0and COVID-19-induced retiform purpura: two overlapping, emerging clinical syndromes"],"prefix":"10.1007","volume":"315","author":[{"given":"Catherine K.","family":"Keim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3036-3825","authenticated-orcid":false,"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Kapila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"2303_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/MOH.0000000000000393","volume":"25","author":"MJ Cascio","year":"2018","unstructured":"Cascio MJ, Jen KY (2018) Cocaine\/levamisole-associated autoimmune syndrome: a disease of neutrophil-mediated autoimmunity. Curr Opin Hematol 25:29\u201336","journal-title":"Curr Opin Hematol"},{"key":"2303_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuint.2013.11.010","volume":"73","author":"T Hofmaier","year":"2014","unstructured":"Hofmaier T, Luf A, Seddik A et al (2014) Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters. Neurochem Int 73:32\u201341","journal-title":"Neurochem Int"},{"key":"2303_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.drugalcdep.2015.01.035","volume":"149","author":"CS Tallarida","year":"2015","unstructured":"Tallarida CS, Tallarida RJ, Rawls SM (2015) Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats. Drug Alcohol Depend 149:145\u2013150","journal-title":"Drug Alcohol Depend"},{"key":"2303_CR4","unstructured":"The Drug Enforcement Administration. National Drug Threat Assessment 2017, October 2017 edn. U.S. Drug Enforcement Administration, Springfield, VA"},{"issue":"49","key":"2303_CR5","first-page":"1381","volume":"58","author":"MD Brackney","year":"2009","unstructured":"Brackney MD (2009) Morb Mortal Wkly Rep 58(49):1381\u20131385","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"2303_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaad.2010.08.024","volume":"65","author":"C Chung","year":"2011","unstructured":"Chung C, Tumeh PC, Birnbaum R et al (2011) Characteristic purpura of the ears, vasculitis, and neutropenia\u2013a potential public health epidemic associated with levamisole-adulterated cocaine. J Am Acad Dermatol 65(4):722-725.e2","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2303_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.semarthrit.2018.07.010","volume":"48","author":"A Dartevel","year":"2019","unstructured":"Dartevel A, Chaigne B, Moachon L et al (2019) Levamisole-induced vasculopathy: a systematic review. Semin Arthritis Rheum 48(5):921\u2013926","journal-title":"Semin Arthritis Rheum"},{"key":"2303_CR8","unstructured":"WHO Director\u2010General's opening remarks at the media briefing on COVID\u201019. World Health Organization (WHO) https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---3-august-2020"},{"issue":"8","key":"2303_CR9","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324(8):782\u2013793. https:\/\/doi.org\/10.1001\/jama.2020.12839","journal-title":"JAMA"},{"issue":"5","key":"2303_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13544","volume":"33","author":"N Almutairi","year":"2020","unstructured":"Almutairi N, Schwartz RA (2020) COVID-19 with dermatologic manifestations and implications: an unfolding conundrum. Dermatol Ther 33(5):e13544. https:\/\/doi.org\/10.1111\/dth.13544","journal-title":"Dermatol Ther"},{"key":"2303_CR11","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.ccc031","author":"S Young","year":"2020","unstructured":"Young S, Fernandez AP (2020) Skin manifestations of COVID-19. Clev Clin J Med. https:\/\/doi.org\/10.3949\/ccjm.87a.ccc031","journal-title":"Clev Clin J Med"},{"issue":"1","key":"2303_CR12","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.jaad.2020.04.094","volume":"83","author":"P Suchonwanit","year":"2020","unstructured":"Suchonwanit P, Leerunyakul K, Kositkuljorn C (2020) Cutaneous manifestations in COVID-19: lessons learned from current evidence. J Am Acad Dermatol 83(1):e57\u2013e60. https:\/\/doi.org\/10.1016\/j.jaad.2020.04.094","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2303_CR13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","volume":"83","author":"EE Freeman","year":"2020","unstructured":"Freeman EE, McMahon DE, Lipoff JB et al (2020) The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol 83(4):1118\u20131129. https:\/\/doi.org\/10.1016\/j.jaad.2020.06.1016","journal-title":"J Am Acad Dermatol"},{"key":"2303_CR14","unstructured":"World Health Organization. (2020) Novel Coronavirus (2019-nCoV): situation report, 209. World Health Organization. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200816-covid-19-sitrep-209.pdf?sfvrsn=5dde1ca2_2"},{"issue":"5","key":"2303_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.dsx.2020.06.008","volume":"14","author":"MJ Dubey","year":"2020","unstructured":"Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S (2020) COVID-19 and addiction. Diabetes Metab Syndr 14(5):817\u2013823. https:\/\/doi.org\/10.1016\/j.dsx.2020.06.008","journal-title":"Diabetes Metab Syndr"},{"issue":"7","key":"2303_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/ph13070155","volume":"13","author":"Y Wei","year":"2020","unstructured":"Wei Y, Shah R (2020) Substance use disorder in the COVID-19 pandemic: a systematic review of vulnerabilities and complications. Pharmaceuticals (Basel) 13(7):155. https:\/\/doi.org\/10.3390\/ph13070155","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"2303_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.medcli.2016.02.015","volume":"146","author":"A Imbern\u00f3n-Moya","year":"2016","unstructured":"Imbern\u00f3n-Moya A, Chico R, Aguilar-Mart\u00ednez A (2016) Cutaneous and mucosal manifestations associated with cocaine use. Med Clin (Barc) 146(12):544\u2013549","journal-title":"Med Clin (Barc)"},{"issue":"6","key":"2303_CR18","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1124\/dmd.112.045021","volume":"40","author":"A Wolford","year":"2012","unstructured":"Wolford A, McDonald TS, Eng H, Hansel S, Chen Y, Bauman J et al (2012) Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab and Dispos 40(6):1067\u20131075","journal-title":"Drug Metab and Dispos"},{"issue":"6","key":"2303_CR19","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00204-017-1947-4","volume":"91","author":"T Brunt","year":"2017","unstructured":"Brunt T, Berg J, Pennings E, Venhuis B (2017) Adverse effects of levamisole in cocaine users: a review and risk assessment. Arch Toxicol 91(6):2303\u20132313","journal-title":"Arch Toxicol"},{"issue":"1","key":"2303_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13000-015-0279-z","volume":"10","author":"AL Nolan","year":"2015","unstructured":"Nolan AL, Jen KY (2015) Pathologic manifestations of levamisole-adulterated cocaine exposure. Diagn Pathol 10(1):48\u201348","journal-title":"Diagn Pathol"},{"issue":"1","key":"2303_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.JAA.0000547746.08181.f7","volume":"32","author":"TC George","year":"2019","unstructured":"George TC, Freet DJ, Cross JM, Huzar TF (2019) Levamisole-induced vasculitis. JAAPA 32(1):23\u201327","journal-title":"JAAPA"},{"issue":"6","key":"2303_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/20009666.2018.1536242","volume":"8","author":"Q Jin","year":"2018","unstructured":"Jin Q, Kant S, Alhariri J, Geetha D (2018) Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis. J Community Hosp Intern Med Perspect 8(6):339\u2013344","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"12","key":"2303_CR23","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.2215\/CJN.03440411","volume":"6","author":"MM Mcgrath","year":"2011","unstructured":"Mcgrath MM, Isakova T, Rennke HG et al (2011) Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol 6(12):2799\u20132805","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2303_CR24","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1097\/RHU.0000000000000813","volume":"25","author":"H Mu\u00f1oz-Vahos","year":"2019","unstructured":"Mu\u00f1oz-Vahos H, Herrera-Uribe A, Arbel\u00e1ez-Cort\u00e9s A et al (2019) Clinical profile of levamisole-adulterated cocaine-induced vasculitis\/vasculopathy: a 30-case series. J Clin Rheumatol 25(3):e16\u2013e26","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"2303_CR25","first-page":"93","volume":"32","author":"AC Agdamag","year":"2018","unstructured":"Agdamag AC, Gevorgyan O, Lawrenz Co M, Hassan S (2018) Multiple cutaneous and mucosal lesions in a patient with cocaine-levamisole-induced vasculopathy syndrome. Proc (Bayl Univ Med Cent) 32(1):93\u201395","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"4","key":"2303_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/RHU.0b013e31820e6822","volume":"17","author":"K Ullrich","year":"2011","unstructured":"Ullrich K, Koval R, Koval E, Bapoje S, Hirsh J (2011) Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol 17(4):193\u2013196","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"2303_CR27","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00296-019-04410-9","volume":"39","author":"F L\u00f6tscher","year":"2019","unstructured":"L\u00f6tscher F, Krusche M, Ruffer N, Kubacki T, Person F, K\u00f6tter I (2019) Cocaine-induced ANCA-associated renal disease: a case-based review. Rheumatol Int 39(11):2005\u20132014","journal-title":"Rheumatol Int"},{"issue":"3","key":"2303_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000456553","volume":"45","author":"D Collister","year":"2017","unstructured":"Collister D, Sathianathan C, Ryz K et al (2017) ANCA associated vasculitis secondary to levamisole-adultered cocaine with associated membranous nephropathy: a case series. Am J Nephrol 45(3):209\u2013216","journal-title":"Am J Nephrol"},{"issue":"1","key":"2303_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12883-015-0467-1","volume":"15","author":"R Vosoughi","year":"2015","unstructured":"Vosoughi R, Schmidt BJ, Vosoughi R (2015) Multifocal leukoencephalopathy in cocaine users: a report of two cases and review of the literature. BMC Neurol 15(1):208\u2013208","journal-title":"BMC Neurol"},{"issue":"1","key":"2303_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/RHU.0000000000000910","volume":"26","author":"SN Emil","year":"2020","unstructured":"Emil SN, Cisneros RD, Penmetsa SH et al (2020) Atypical chronic inflammatory ANCA-positive deforming arthritis after cocaine-levamisole exposure. J Clin Rheumatol 26(1):24\u201332","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"2303_CR31","first-page":"192","volume":"16","author":"A Ogunbameru","year":"2015","unstructured":"Ogunbameru A, Jandali M, Issa A et al (2015) Acute pancreatitis as initial presentation of cocaine-induced vasculitis: a case report. J Pancreas 16(2):192\u2013194","journal-title":"J Pancreas"},{"issue":"1","key":"2303_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/BOR.0b013e32835b4449","volume":"25","author":"J Graf","year":"2013","unstructured":"Graf J (2013) Rheumatic manifestations of cocaine use. Curr Opin Rheumatol 25(1):50\u201355","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"2303_CR33","first-page":"638","volume":"56","author":"C Lood","year":"2017","unstructured":"Lood C, Hughes GC (2017) Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity. Rheumatology (Oxford) 56(4):638\u2013643","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"2303_CR34","doi-asserted-by":"publisher","first-page":"e89780","DOI":"10.1172\/jci.insight.89780","volume":"2","author":"C Carmona-Rivera","year":"2017","unstructured":"Carmona-Rivera C, Purmalek MM, Moore E et al (2017) A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity. JCI Insight 2(3):e89780\u2013e89780","journal-title":"JCI Insight"},{"issue":"1","key":"2303_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/BOR.0000000000000450","volume":"30","author":"D S\u00f6derberg","year":"2018","unstructured":"S\u00f6derberg D, Segelmark M (2018) Neutrophil extracellular traps in vasculitis, friend or foe? Curr Opin Rheumatol 30(1):16\u201323","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"2303_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41419-020-2497-x","volume":"11","author":"S Yousefi","year":"2020","unstructured":"Yousefi S, Simon D, Stojkov D, Karsonova A, Karaulov A, Simon H-U (2020) In vivo evidence for extracellular DNA trap formation. Cell Death Dis 11(4):300\u2013315","journal-title":"Cell Death Dis"},{"issue":"1","key":"2303_CR37","doi-asserted-by":"publisher","first-page":"16556","DOI":"10.1038\/s41598-019-53058-9","volume":"9","author":"A Sofoluwe","year":"2019","unstructured":"Sofoluwe A, Bacchetta M, Badaoui M, Kwak BR, Chanson M (2019) ATP amplifies NADPH-dependent and -independent neutrophil extracellular trap formation. Sci Rep 9(1):16556","journal-title":"Sci Rep"},{"issue":"1","key":"2303_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1515\/cclm-2012-0519","volume":"51","author":"J Shea","year":"2012","unstructured":"Shea J (2012) Bioanalytical methods for quantitation of levamisole, a widespread cocaine adulterant. Clin Chem Lab Med 51(1):205\u2013212","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"2303_CR39","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jaad.2019.07.113","volume":"82","author":"C Georgesen","year":"2020","unstructured":"Georgesen C, Fox LP, Harp J (2020) Retiform purpura: workup and therapeutic considerations in select conditions. J Am Acad Dermatol 82(4):799\u2013816","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2303_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jaad.2019.07.112","volume":"82","author":"C Georgesen","year":"2020","unstructured":"Georgesen C, Fox LP, Harp J (2020) Retiform purpura: a diagnostic approach. J Am Acad Dermatol 82(4):783\u2013796a","journal-title":"J Am Acad Dermatol"},{"key":"2303_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2133.1992.tb00114.x","volume":"127","author":"RA Schwartz","year":"1992","unstructured":"Schwartz RA, Churg J (1992) Churg-Strauss syndrome. Brit J Dermatol 127:199\u2013204","journal-title":"Brit J Dermatol"},{"issue":"3","key":"2303_CR42","first-page":"247","volume":"6","author":"L Schroedl","year":"2020","unstructured":"Schroedl L, Kim E, Hoffman MD (2020) Iatrogenic Kaposi sarcoma presenting as retiform purpura during treatment of bullous pemphigoid. J Am Acad Dermatol 6(3):247\u2013249","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"2303_CR43","doi-asserted-by":"publisher","first-page":"e233344","DOI":"10.1136\/bcr-2019-233344","volume":"12","author":"R Calado","year":"2019","unstructured":"Calado R, Relvas M, Brites MM, Cardoso JC (2019) Acute retiform purpura caused by\u00a0Morganella\u00a0morganii. BMJ Case Rep 12(12):e233344","journal-title":"BMJ Case Rep"},{"issue":"12","key":"2303_CR44","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1002\/art.30590","volume":"63","author":"J Graf","year":"2011","unstructured":"Graf J, Lynch K, Yeh CL et al (2011) Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine. Arthritis Rheum 63(12):3998\u20134001","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2303_CR45","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1097\/RHU.0000000000001123","volume":"26","author":"A Raheemullah","year":"2020","unstructured":"Raheemullah A, Melhem M, Andruska N (2020) Cocaine cessation for levamisole-induced vasculitis: treating the underlying disease. J Clin Rheumatol 26(8):e276\u2013e278","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"2303_CR46","first-page":"E15","volume":"98","author":"J Mandrell","year":"2016","unstructured":"Mandrell J, Kranc CL (2016) Prednisone and vardenafil hydrochloride for refractory levamisole-induced vasculitis. Cutis 98(2):E15\u2013E19","journal-title":"Cutis"},{"key":"2303_CR47","doi-asserted-by":"publisher","DOI":"10.5070\/D36G18R9CV","author":"T Pearson","year":"2012","unstructured":"Pearson T, Bremmer M, Cohen J, Driscoll M (2012) Vasculopathy related to cocaine adulterated with levamisole: A review of the literature. Dermatol Online J. https:\/\/doi.org\/10.5070\/D36G18R9CV","journal-title":"Dermatol Online J"},{"issue":"12","key":"2303_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-015-0545-9","volume":"17","author":"RG Grau","year":"2015","unstructured":"Grau RG (2015) Drug-induced vasculitis: new insights and a changing lineup of suspects. Curr Rheumatol Rep 17(12):1\u201310","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"2303_CR49","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1097\/BCR.0000000000000428","volume":"38","author":"G Mcevenue","year":"2017","unstructured":"Mcevenue G, Brichacek M, Logsetty S, Shahrokhi S (2017) Surgical management of levamisole-adulterated cocaine induced soft tissue necrosis: case study and treatment algorithm. J Burn Care Res 38(3):e638\u2013e646","journal-title":"J Burn Care Res"},{"issue":"5","key":"2303_CR50","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1111\/jdv.16387","volume":"34","author":"S Recalcati","year":"2020","unstructured":"Recalcati S (2020) Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 34(5):e212\u2013e213. https:\/\/doi.org\/10.1111\/jdv.16387","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"2303_CR51","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1111\/jdv.16689","volume":"34","author":"X Bosch-Amate","year":"2020","unstructured":"Bosch-Amate X, Giavedoni P, Podlipnik S, Andreu-Febrer C, Sanz-Beltran J, Garcia-Herrera A, Al\u00f3s L, Mascar\u00f3 JM (2020) Retiform purpura as a dermatological sign of coronavirus disease 2019 (COVID-19) coagulopathy. J Eur Acad Dermatol Venereol 34(10):e548\u2013e549","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2303_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjd.19415","volume":"184","author":"C Magro","year":"2021","unstructured":"Magro C, Mulvey JJ, Laurence J, Sanders S, Crowson AN, Grossman M, Harp J, Nuovo G (2021) The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. Br J Dermatol 184(1):141\u2013150","journal-title":"Br J Dermatol"},{"issue":"9","key":"2303_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamadermatol.2020.2800","volume":"156","author":"C Droesch","year":"2020","unstructured":"Droesch C, Do MH, DeSancho M, Lee EJ, Magro C, Harp J (2020) Livedoid and purpuric skin eruptions associated with coagulopathy in severe COVID-19. JAMA Dermatol 156(9):1\u20133","journal-title":"JAMA Dermatol"},{"key":"2303_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa760","author":"KE Hanson","year":"2020","unstructured":"Hanson KE, Caliendo AM, Arias CA et al (2020) Infectious diseases society of america guidelines on the diagnosis of COVID-19. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa760","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2303_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14053","volume":"33","author":"P Singh","year":"2020","unstructured":"Singh P, Schwartz RA (2020) Disseminated intravascular coagulation: a devastating systemic disorder of special concern with COVID-19. Dermatol Ther 33(6):e14053. https:\/\/doi.org\/10.1111\/dth.14053","journal-title":"Dermatol Ther"},{"issue":"1","key":"2303_CR56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/bjd.19163","volume":"183","author":"C Galv\u00e1n Casas","year":"2020","unstructured":"Galv\u00e1n Casas C, Catal\u00e0 A, Carretero Hern\u00e1ndez G et al (2020) Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 183(1):71\u201377. https:\/\/doi.org\/10.1111\/bjd.19163","journal-title":"Br J Dermatol"},{"issue":"7","key":"2303_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102567","volume":"19","author":"Y Jamilloux","year":"2020","unstructured":"Jamilloux Y, Henry T, Belot A et al (2020) Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev 19(7):102567. https:\/\/doi.org\/10.1016\/j.autrev.2020.102567","journal-title":"Autoimmun Rev"},{"key":"2303_CR58","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3389\/fimmu.2019.03150","volume":"10","author":"M Nosaka","year":"2020","unstructured":"Nosaka M, Ishida Y, Kimura A et al (2020) Crucial involvement of IL-6 in thrombus resolution in mice via macrophage recruitment and the induction of proteolytic enzymes. Front Immunol 10:3150","journal-title":"Front Immunol"},{"issue":"1","key":"2303_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13054-020-03048-5","volume":"24","author":"J Jalkanen","year":"2020","unstructured":"Jalkanen J, Hollm\u00e9n M, Jalkanen S (2020) Interferon beta-1a for COVID-19: critical importance of the administration route. Crit Care 24(1):335","journal-title":"Crit Care"},{"key":"2303_CR60","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at\u00a0https:\/\/www.covid19treatmentguidelines.nih.gov\/. Accessed 12 Jun 2021"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02303-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-021-02303-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02303-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T02:26:43Z","timestamp":1676860003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-021-02303-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["2303"],"URL":"https:\/\/doi.org\/10.1007\/s00403-021-02303-1","relation":{},"ISSN":["1432-069X"],"issn-type":[{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"assertion":[{"value":"10 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Keim: nothing to disclose; Dr. Schwartz: nothing to disclose; Dr. Kapila: nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}